T
Tourmaline Bio Inc.
TBIOHealth Care· Houston, TX, US
LAYOFFS TRACKED
1
LAST EVENT
May 29, 2026
MARKET CAP
—
EMPLOYEES
45
Tourmaline Bio is a clinical-stage biotechnology company focused on the discovery and development of targeted antibody-based therapies for patients with genetically defined cancers and other serious diseases. The company develops next-generation antibody-drug conjugates (ADCs) and antibody-based therapeutics to address unmet medical needs.
Layoff timeline
1 EVENTStories from here
No one has shared a story from Tourmaline Bio yet. Went through a layoff here? Your experience helps others feel less alone.
Share your story →Get alerts for Tourmaline Bio
We'll email you the moment a new layoff is reported here.